DSG Pharma Consulting, LLCLa Jolla, California, United States
Disclosure information not submitted.
232 - MDL-001: A Broad-Spectrum Antiviral Targeting the Thumb-1 Domain of Viral Polymerases
Monday, October 20, 20253:39 PM - 3:51 PM US ET